Medicare Spending Forecast For Leqembi Reflects CMS Angst About Alzheimer’s Drug Costs

The suits are an early test of the Arkansas law banning company ownership of PBMs and pharmacies in the state, as other states consider similar legislation.

An unintended consequence of a provision framed as an administrative change in the bill could significantly reduce medication adherence among low-income older adults and increase mortality, a study found.

Despite pushback by industry, the government is standing by its new statutory scheme rebate rates for branded medicines, including one that doubles the rate that companies must repay on the sales of newer products to the National Health Service to 31.3%.

Companies operating in Argentina may get their medicines to the market more quickly thanks to new updates to the medicines authorization system.